American cancer society guidelines for the early detection of cancer

Ca-A Cancer Journal for Clinicians

Volumn 50, Issue 1, 2000, Pages 34-49

  Smith, Robert A ^a   Melltin, Curtis J ^b   Davis, Kourtney Johnston ^c,d   Eyre, Harmon ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c GLAXOSMITHKLINE   (United States)

^d ACS

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; HUMAN; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH; REVIEW; UTERINE CERVIX CANCER;

EID: 12944317277     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.50.1.34     Document Type: Review

References (75)

1. American Cancer Society: Guidelines for the cancer-related checkup: Recommendations and rationale. CA Cancer J Clin 1980;30:4-50.
2. Fink D: Guidelines for the cancer-related checkup. Atlanta, American Cancer Society, 1991.
3. Rimer BK, Bluman LG: The psychosocial consequences of mammography. J Natl Cancer Inst Monog 1997;22:131-138.
4. Dodd GD: American Cancer Society guidelines on screening for breast cancer: An overview. Cancer 1992;69(7 Suppl):1885-7.
5. Leitch AM, et al: American Cancer Society guidelines for the early detection of breast cancer: Update 1997. CA Cancer J Clin 1997;47:150-153.
6. Smith RA:. Breast cancer screening guidelines. Womens Health Issues. 1992;2:212-217.
7. Tabar L, et al: Efficacy of breast cancer screening by age: New results from the Swedish Two-County Trial. Cancer 1995;75:2507-2517.
8. Tabar L, et al: Tumour development, histology and grade of breast cancers: Prognosis and progression. Int J Cancer 1996;66:413-419.
9. Hendrick RE, et al: Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22:87-92.
10. Tabar L, et al: The natural history of breast carcinoma: What have we learned from screening? Cancer 1999;86:449-462.
11. Tabar L, et al: Recent results from the Swedish Two-County Trial: The effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst Monogr 1997;22:43-47.
12. Swedish Cancer Society and the Swedish National Board of Health and Welfare: Breast cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996;68:693-699.
13. Bassett L, et al: Quality Determinants of Mammography. Clinical Practice Guideline No. 13. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, 1994; 1994.
14. Burke W, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer: I. Hereditary nonpolyposis colon cancer: Cancer Genetics Studies Consortium. JAMA 1997;277:915-919.
15. Breslow L: A history of cancer control in the US with emphasis on the period 1946-1971. Los Angeles: University of California at Los Angeles School of Public Health;1977.
16. Morrison AS: Screening in Chronic Disease, ed. 2. New York, Oxford University Press, 1992.
17. Cox JT, et al: Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-954.
18. Cuzick J, et al: Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533-1536.
19. Kiviat NB, et al: Prevalence and cytologic manifestations of human papilloma virus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, and 56 among 500 consecutive women. Int J Gynecol Pathol 1992;11:197-203.
20. Koutsky LA, et al: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-1278.
21. Schneider A, Koutsky LA: Natural history and epidemiological features of genital HPV infection. IARC Sci Publ 1992;119:25-52.
22. van Muyden RC, et al: Detection and typing of human papillomavirus in cervical carcinomas in Russian women: A prognostic study. Cancer 1999;85:2011-2016.
23. Jenkins D, Sherlaw-Johnson C, Gallivan S: Assessing the role of HPV testing in cervical cancer screening. Papilloma Report. 1998;9:89-101.
24. Franco EL, Rohan TE, Villa LL: Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999;91:506-511.
25. Walboomers JM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
26. American Cancer Society. The American Cancer Society Guideline for the cancer-related checkup: An update. Atlanta: American Cancer Society, 1993.
27. Shingleton HM, et al: The current status of the Papanicolaou smear. CA Cancer J Clin 1995;45:305-320.
28. US Preventive Services Task Force: Guide to Clinical Preventive Services, ed. 2. Baltimore, Williams & Wilkins, 1996.
29. American College of Physicians: Screening for cervical cancer. In: Eddy DM (ed) Common screening tests. Philadelphia: American College of Physicians, 1991.
30. Canadian Task Force on the Periodic Health Examination: The Canadian Guide to Clinical Preventive Health Care. Ottawa, Health Canada, 1994.
31. Eifel PJ, Berek JS, Thigpen JT: Cancer of the cervix, vagina, and vulva. In: Devita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology, ed. 5. Philadelphia, Lippincott-Raven, 1997.
32. Gefeller O, Windeler J: Risk factors for cervical cancer Comments on attributable risk calculations and the evaluation of screening in case-control studies. Int J Epidemiol 1991;20:1140-1143.
33. Nakagawa S, et al: Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer 1996;78:1935-1941.
34. Thomas DB, Ray RM: Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix: The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol 1996; 144:281-289.
35. Stephenson RA, Stanford JL: Population-based prostate cancer trends in the United States: Patterns of change in the era of prostate-specific antigen. World J Urol 1997;15:331-335.
36. Mettlin CJ, Murphy GP: Why is the prostate cancer death rate declining in the United States? [published erratum appears in Cancer 1998 May 1;82:1802]. Cancer 1998;82:249-251.
37. Mettlin C: Changes in patterns of prostate cancer care in the United States: Results of American College of Surgeons Commission on Cancer studies, 1974-1993. Prostate 1997;32:221-226.
38. Wang MC, et al: Purification of a human prostate specific antigen. Invest Urol 1979;17:159-163.
39. Catalona WJ, et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer [published erratum appears in N Engl J Med 1991;325:1324]. N Engl J Med 1991;324:1156-1161.
40. Mettlin C, et al: The American Cancer Society National Prostate Cancer Detection Project: Findings on the detection of early prostate cancer in 2425 men. Cancer 1991;67:2949-2958.
41. Rics L, et al: SEER Cancer Statistics Review, 1973-1995. Bethesda, MD: National Cancer Institute, 1998.
42. Mettlin CJ, et al: Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection Project. Cancer 1997;80:1814-1817.
43. Collins MM, Barry MJ: Controversies in prostate cancer screening: Analogies to the early lung cancer screening debate. JAMA 1996;276:1976-1979.
44. Hall RR: Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: The argument against. Eur Urol 1996;29(suppl 2):24-26.
45. Albertson PC: Screening for prostate cancer is neither appropriate nor cost-effective. Euro Clin North America 1996;23:521-530.
46. Mettlin C, et al: Defining and updating the American Cancer Society guidelines for the cancer-related checkup: Prostate and endometrial cancers. CA Cancer J Clin 1993;43:42-46.
47. von Eschenbach A, et al: American Cancer Society guideline for the early detection of prostate cancer: Update 1997. CA Cancer J Clin 1997;47:261-264.
48. American College of Physicians: Screening for prostate cancer. Ann Intern Med 1997;126:480-484.
49. Young G, St. John J: Selecting an occult blood test for use as a screening tool for large bowel cancer. Front Gastrointest Res 1991;18:135-156.
50. Ransohoff DF, Lang CA: Screening for colorectal cancer with the fecal occult blood test: A background paper American College of Physicians. Ann Intern Med 1997;126:811-822.
51. Wagner JL, et al: Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B (eds) Prevention and Early Detection of Colorectal Cancer. Philadelphia, Saunders, 1996.
52. Winawer SJ, et al: Colorectal cancer screening: Clinical guidelines and rationale [published errata appear in Gastroenterology 1997;112:1060 and 1998;114:625]. Gastroenterology 1997;112:594-642.
53. Byers T, et al: American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997. CA Cancer J Clin 1997;47:154-160.
54. American Academy of Family Physicians: Age charts for the periodic health examination. Kansas City: American Academy of Family Physicians, 1994.
55. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services, ed. 2. Baltimore, Williams & Wilkins, 1996.
56. Eddy D: Screening for lung cancer. Philadelphia, American College of Physicians, 1991.
57. Fontana RS: The Mayo Lung Project: A perspective. Presented at the International Conference on Prevention and Early Diagnosis of Lung Cancer Varese, Italy, 1998.
58. Fontana RS, et al: Screening for lung cancer. A critique of the Mayo Lung Project Cancer 1991;67(4 Suppl):1155-1164.
59. Strauss GM: Measuring effectiveness of lung cancer screening: From consensus to controversy and back. Chest 1997;112(4 Suppl):216S-228S.
60. Kramer BS, et al: A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 1993;71(2 Suppl):589-593.
61. Henschke CI, et al: Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 1999;354:99-105.
62. Wolpaw DR: Early detection in lung cancer: Case finding and screening. Med Clin North Am 1996;80:63-82.
63. Horton JA, Romans MC, Cruess DF: Mammography attitudes and usage study, 1992. Womens Health Issues. 1992;2:180-186.
64. Smith RA, Haynes S: Barriers to screening for breast cancer. Cancer 1992;69(7 Suppl):1968-1978.
65. Rimer BK, et al: Why do some women get regular mammograms? Am J Prev Med 1991;7:69-74.
66. National Cancer Institute Breast Cancer Screening Consortium: Screening mammography: A missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies. JAMA 1990;264:54-58.
67. Vernon SW: Participation in colorectal cancer screening: A review. J Natl Cancer Inst 1997;89:1406-1422.
68. Kiefe CI, et al: Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 1998;13:357-365.
69. Rimer BK: Current use and how to increase mammography screening in women. Surg Oncol Clin N Am 1997;6:203-211.
70. Dietrich AJ, et al: Cancer Improving early detection and prevention: A community practice randomised trial. BMJ 1992;304:687-691.
71. Dietrich AJ, Woodruff, CB, Carney PA: Changing office routines to enhance preventive care: The preventive GAPS approach. Arch Fam Med 1994;3:176-183.
72. Gann P, Melville SK, Luckmann R: Characteristics of primary care office systems as predictors of mammography utilization. Ann Intern Med 1993;118:893-898.
73. Garr DR, et al: The effect of routine use of computer-generated preventive reminders in a clinical practice. Am J Prev Med 1993;9:55-61.
74. McPhee SJ, et al: Promoting cancer screening: A randomized, controlled trial of three interventions. Arch Intern Med 1989;149:1866-1872.
75. McPhee SJ, Bird JA, Fordham D, et al: Promoting cancer prevention activities by primary care physicians: Results of a randomized, controlled trial. JAMA 1991;266:538-544.